Literature DB >> 7685740

Reactivity profile of human anti-82-kilodalton rhoptry protein antibodies generated during natural infection with Plasmodium falciparum.

R F Howard1, J B Jensen, H L Franklin.   

Abstract

Immunization of monkeys with the 82-kDa rhoptry protein (p82) of Plasmodium falciparum can protect them against a lethal blood stage challenge, and monoclonal antibodies to p82 inhibit parasite growth in vitro. The role that a p82-specific immune response might play in human immunity to the parasite is not known. To determine to what extent humans produce antibodies to p82 following infection with P. falciparum, sera from individuals believed to be hyperimmune, semi-immune, or never infected with the parasite were examined. Portions of the p82 gene were expressed separately as fusion proteins and used on immunoblots to test for antibodies to the recombinant proteins. All but 1 of the 30 immune sera possessed antibodies to p82, while nonimmune sera produced, at best, only a marginal signal to the fusion proteins. The signal intensity produced with the human immune sera depended on the region of p82 being assayed, with the N-terminal 37% of p82 producing stronger signals than more C-terminal parts of p82. This N-terminal domain contains a tandem octapeptide repeat (consensus KSSSPSXT/V) of the structure (repeat)2-Q-T-S-G-S/L-(repeat)3. It is shown here that the sequence of this repetitive motif is conserved among four parasite isolates at both the nucleotide and amino acid levels; the five-residue repeat interruption peptide QTSGS/L separating the two sets of repeats contains the only amino acid substitution (Ser or Leu) detected in this region to date. Despite their conservation of structure, the repeats do not appear to be the only epitope recognized by the human antibodies, since sera which recognize the N-terminal fusion protein containing the repeats also bind a related protein after truncation and removal of the repeats. These results indicate that the structurally conserved p82 molecule contains multiple B-cell epitopes and is likely to be immunogenic in most individuals during natural infections with P. falciparum. These observations are consistent with the idea that antibodies to p82 generated during parasite infection have a role in the development of immunity to the organism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685740      PMCID: PMC280945          DOI: 10.1128/iai.61.7.2960-2965.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Gamma-globulin and acquired immunity to human malaria.

Authors:  S COHEN; I A McGREGOR; S CARRINGTON
Journal:  Nature       Date:  1961-11-25       Impact factor: 49.962

2.  High-expression vectors with multiple cloning sites for construction of trpE fusion genes: pATH vectors.

Authors:  T J Koerner; J E Hill; A M Myers; A Tzagoloff
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

3.  Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products.

Authors:  D Marchuk; M Drumm; A Saulino; F S Collins
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

4.  Inhibitory monoclonal antibodies recognise epitopes adjacent to a proteolytic cleavage site on the RAP-1 protein of Plasmodium falciparum.

Authors:  P Harnyuttanakorn; J S McBride; S Donachie; H G Heidrich; R G Ridley
Journal:  Mol Biochem Parasitol       Date:  1992-10       Impact factor: 1.759

5.  Specificity of protective immunity produced by x-irradiated Plasmodium berghei sporozoites.

Authors:  R S Nussenzweig; J P Vanderberg; H Most; C Orton
Journal:  Nature       Date:  1969-05-03       Impact factor: 49.962

6.  Penetration of erythrocytes by merozoites of mammalian and avian malarial parasites.

Authors:  R Ladda; M Aikawa; H Sprinz
Journal:  J Parasitol       Date:  1969-06       Impact factor: 1.276

Review 7.  Immunity to asexual erythrocytic stages of Plasmodium falciparum: role of defined antigens in the humoral response.

Authors:  L H Perrin; R Dayal
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

8.  Inhibition of P. falciparum growth in human erythrocytes by monoclonal antibodies.

Authors:  L H Perrin; E Ramirez; P H Lambert; P A Miescher
Journal:  Nature       Date:  1981-01-22       Impact factor: 49.962

9.  Expression of Plasmodium falciparum surface antigens in Escherichia coli.

Authors:  F Ardeshir; J E Flint; R T Reese
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

10.  Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes.

Authors:  F Zavala; A H Cochrane; E H Nardin; R S Nussenzweig; V Nussenzweig
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more
  7 in total

1.  Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro.

Authors:  R Moreno; F Pöltl-Frank; D Stüber; H Matile; M Mutz; N A Weiss; G Pluschke
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Assessment of the humoral immune response against Plasmodium falciparum rhoptry-associated proteins 1 and 2.

Authors:  A Stowers; D Taylor; N Prescott; Q Cheng; J Cooper; A Saul
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

3.  Evidence for negative selection on the gene encoding rhoptry-associated protein 1 (RAP-1) in Plasmodium spp.

Authors:  M Andreína Pacheco; Elizabeth M Ryan; Amanda C Poe; Leonardo Basco; Venkatachalam Udhayakumar; Williams E Collins; Ananias A Escalante
Journal:  Infect Genet Evol       Date:  2010-04-02       Impact factor: 3.342

4.  Seroprevalence and specificity of human responses to the Plasmodium falciparum rhoptry protein Rhop-3 determined by using a C-terminal recombinant protein.

Authors:  J C Yang; R E Blanton; C L King; H Fujioka; M Aikawa; T Y Sam-Yellowe
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

5.  Analysis of inhibitory epitopes in the Plasmodium falciparum rhoptry protein RAP-1 including identification of a second inhibitory epitope.

Authors:  R F Howard; K C Jacobson; E Rickel; J Thurman
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

6.  A longitudinal study of human antibody responses to Plasmodium falciparum rhoptry-associated protein 1 in a region of seasonal and unstable malaria transmission.

Authors:  P N Fonjungo; I M Elhassan; D R Cavanagh; T G Theander; L Hviid; C Roper; D E Arnot; J S McBride
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

7.  Antigenicity of recombinant proteins derived from rhoptry-associated protein 1 of Plasmodium falciparum.

Authors:  P N Fonjungo; D Stüber; J S McBride
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.